Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002697,GO:0002697,regulation of immune effector process,14/41,353/18800,1.16751674520183e-14,1.54812720413763e-11,8.82396866373593e-12,ADGRE2/BST2/CD74/CRTAM/GRN/HLA-E/ICAM1/IL4R/LAG3/SEMA7A/SLAMF8/SPON2/TNFRSF1B/TNFRSF4,14
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,8/41,167/18800,2.4394746702599402e-09,1.12148425045399e-06,6.39220204672514e-07,BST2/CD74/HLA-E/IL4R/SEMA7A/SPON2/TNFRSF1B/TNFRSF4,8
GO:0002443,GO:0002443,leukocyte mediated immunity,10/41,457/18800,3.72803060119802e-08,8.23894762864762e-06,4.6960104765968e-06,ADGRE2/BST2/CD74/CRTAM/HLA-E/ICAM1/IL4R/LAG3/SPON2/TNFRSF1B,10
GO:0070663,GO:0070663,regulation of leukocyte proliferation,8/41,254/18800,6.46332959090007e-08,1.10523216004175e-05,6.29956887282666e-06,BST2/CD74/CRTAM/CSF1/HLA-E/TNFRSF1B/TNFRSF4/VCAM1,8
GO:0002367,GO:0002367,cytokine production involved in immune response,6/41,100/18800,7.52722943908576e-08,1.1090118040253e-05,6.32111197340769e-06,BST2/CD74/HLA-E/SEMA7A/SPON2/TNFRSF1B,6
GO:1903131,GO:1903131,mononuclear cell differentiation,9/41,433/18800,3.05895416944632e-07,3.44984977134836e-05,1.96633494945473e-05,CD74/CD79B/CRTAM/CSF1/IL4R/LAG3/LY9/SLAMF8/VCAM1,9
GO:0002440,GO:0002440,production of molecular mediator of immune response,8/41,312/18800,3.12203599217046e-07,3.44984977134836e-05,1.96633494945473e-05,BST2/CD74/HLA-E/IL4R/SEMA7A/SPON2/TNFRSF1B/TNFRSF4,8
GO:0070661,GO:0070661,leukocyte proliferation,8/41,330/18800,4.77700384506766e-07,4.87254392196901e-05,2.77723786296241e-05,BST2/CD74/CRTAM/CSF1/HLA-E/TNFRSF1B/TNFRSF4/VCAM1,8
GO:1902105,GO:1902105,regulation of leukocyte differentiation,7/41,283/18800,2.35931003597536e-06,0.0001738025059835,9.90634272415386e-05,CD74/CRTAM/CSF1/FSTL3/IL4R/LAG3/SLAMF8,7
GO:0050863,GO:0050863,regulation of T cell activation,7/41,342/18800,8.18936201778213e-06,0.000472134523286,0.0002691058090969,CD74/CRTAM/HLA-E/IL4R/LAG3/TNFRSF1B/VCAM1,7
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,6/41,230/18800,9.87315744683561e-06,0.0005454919489376,0.000310917852931,CD74/CRTAM/HLA-E/TNFRSF1B/TNFRSF4/VCAM1,6
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,7/41,370/18800,1.36495854654627e-05,0.0006366977235372,0.0003629030447723,CD74/HLA-E/ICAM1/IL18BP/IL4R/LY9/TNFRSF1B,7
GO:0046718,GO:0046718,viral entry into host cell,5/41,146/18800,1.57778992536491e-05,0.0006748869164625,0.0003846700055728,CD74/EPHA2/ICAM1/SCARB2/TNFRSF4,5
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,7/41,381/18800,1.64921346569881e-05,0.0006833928298489,0.0003895181803854,CD74/CRTAM/HLA-E/ICAM1/IL4R/LAG3/VCAM1,7
GO:0050900,GO:0050900,leukocyte migration,7/41,384/18800,1.73472193038087e-05,0.0006970428120257,0.0003972983559851,ADGRE2/CD74/CRTAM/CSF1/ICAM1/SLAMF8/VCAM1,7
GO:0045954,GO:0045954,positive regulation of natural killer cell mediated cytotoxicity,3/41,27/18800,2.71534735743004e-05,0.0010287287417006,0.0005863517000405,CRTAM/HLA-E/LAG3,3
GO:0002366,GO:0002366,leukocyte activation involved in immune response,6/41,285/18800,3.31463560554861e-05,0.0012104467848783,0.0006899268012563,ADGRE2/CD74/GRN/ICAM1/IL4R/LY9,6
GO:0001910,GO:0001910,regulation of leukocyte mediated cytotoxicity,4/41,85/18800,3.46885202303007e-05,0.0012104467848783,0.0006899268012563,CRTAM/HLA-E/ICAM1/LAG3,4
GO:0046651,GO:0046651,lymphocyte proliferation,6/41,296/18800,4.09563447739195e-05,0.0013037486099137,0.0007431066935921,CD74/CRTAM/HLA-E/TNFRSF1B/TNFRSF4/VCAM1,6
GO:0050777,GO:0050777,negative regulation of immune response,5/41,179/18800,4.20001483868532e-05,0.0013037486099137,0.0007431066935921,GRN/HLA-E/IL4R/PDCD1/SLAMF8,5
GO:0045785,GO:0045785,positive regulation of cell adhesion,7/41,446/18800,4.51421468103207e-05,0.0013037486099137,0.0007431066935921,ADGRG1/CD74/CSF1/FSTL3/HLA-E/IL4R/VCAM1,7
GO:0022614,GO:0022614,membrane to membrane docking,2/41,5/18800,4.62113006530504e-05,0.0013037486099137,0.0007431066935921,ICAM1/VCAM1,2
GO:0060266,GO:0060266,negative regulation of respiratory burst involved in inflammatory response,2/41,5/18800,4.62113006530504e-05,0.0013037486099137,0.0007431066935921,GRN/SLAMF8,2
GO:0060326,GO:0060326,cell chemotaxis,6/41,315/18800,5.78831417581087e-05,0.001532470988291,0.0008734731837683,ADGRE2/CD74/CSF1/EPHA2/SLAMF8/VCAM1,6
GO:0019058,GO:0019058,viral life cycle,6/41,317/18800,5.99492897743506e-05,0.001532470988291,0.0008734731837683,BST2/CD74/EPHA2/ICAM1/SCARB2/TNFRSF4,6
GO:0002695,GO:0002695,negative regulation of leukocyte activation,5/41,193/18800,6.00969015016102e-05,0.001532470988291,0.0008734731837683,CD74/CRTAM/GRN/IL4R/LAG3,5
GO:0031341,GO:0031341,regulation of cell killing,4/41,100/18800,6.56118504216163e-05,0.0016103017339915,0.0009178349170484,CRTAM/HLA-E/ICAM1/LAG3,4
GO:0001819,GO:0001819,positive regulation of cytokine production,7/41,475/18800,6.71769292560098e-05,0.0016103017339915,0.0009178349170484,CD74/CRTAM/HLA-E/IL4R/LY9/SEMA7A/SPON2,7
GO:0060268,GO:0060268,negative regulation of respiratory burst,2/41,6/18800,6.92211152620806e-05,0.0016103017339915,0.0009178349170484,GRN/SLAMF8,2
GO:0106014,GO:0106014,regulation of inflammatory response to wounding,2/41,6/18800,6.92211152620806e-05,0.0016103017339915,0.0009178349170484,GRN/SIGLEC10,2
GO:1905671,GO:1905671,regulation of lysosome organization,2/41,6/18800,6.92211152620806e-05,0.0016103017339915,0.0009178349170484,GRN/SCARB2,2
GO:0042113,GO:0042113,B cell activation,6/41,336/18800,8.26820547908066e-05,0.0017683291073001,0.0010079068818302,BST2/CD74/CD79B/SLAMF8/TNFRSF4/VCAM1,6
GO:0002536,GO:0002536,respiratory burst involved in inflammatory response,2/41,8/18800,0.000128855774954,0.0025501904117769,0.0014535498258758,GRN/SLAMF8,2
GO:0002274,GO:0002274,myeloid leukocyte activation,5/41,232/18800,0.0001429879737677,0.0026704514537475,0.001522095851227,ADGRE2/CD74/CSF1/GRN/IL4R,5
GO:0050868,GO:0050868,negative regulation of T cell activation,4/41,125/18800,0.0001559111477387,0.0028713636375224,0.0016366111707081,CD74/CRTAM/IL4R/LAG3,4
GO:0007188,GO:0007188,adenylate cyclase-modulating G protein-coupled receptor signaling pathway,5/41,244/18800,0.0001808927458698,0.0032155314700478,0.001832778912038,ADGRE1/ADGRE2/ADGRE5/ADGRG1/MARCO,5
GO:0007157,GO:0007157,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,3/41,51/18800,0.0001864243318046,0.0032155314700478,0.001832778912038,CRTAM/ICAM1/VCAM1,3
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,4/41,131/18800,0.0001867239239771,0.0032155314700478,0.001832778912038,CRTAM/HLA-E/ICAM1/LAG3,4
GO:0032102,GO:0032102,negative regulation of response to external stimulus,6/41,429/18800,0.0003115925688871,0.0046423791724083,0.002646049254417,GRN/HLA-E/SEMA7A/SIGLEC10/SLAMF8/TNFRSF1B,6
GO:0043030,GO:0043030,regulation of macrophage activation,3/41,62/18800,0.0003329764012336,0.0048519418465478,0.00276549515426,CD74/GRN/IL4R,3
GO:0032103,GO:0032103,positive regulation of response to external stimulus,6/41,442/18800,0.0003654005381814,0.0051544799322192,0.0029379348982562,CD74/CRTAM/CSF1/GRN/HLA-E/LAG3,6
GO:0046631,GO:0046631,alpha-beta T cell activation,4/41,158/18800,0.0003817504735686,0.0052333113111131,0.0029828669694206,CRTAM/HLA-E/IL4R/LY9,4
GO:0042267,GO:0042267,natural killer cell mediated cytotoxicity,3/41,72/18800,0.0005172077956058,0.0067902726433005,0.003870299085409,CRTAM/HLA-E/LAG3,3
GO:0070372,GO:0070372,regulation of ERK1 and ERK2 cascade,5/41,311/18800,0.0005517073501302,0.0070238568236998,0.0040034366908125,CD74/EPHA2/ICAM1/MARCO/SEMA7A,5
GO:0002830,GO:0002830,positive regulation of type 2 immune response,2/41,17/18800,0.0006181332439466,0.0075196759768185,0.0042860421936617,CD74/IL4R,2
GO:0090594,GO:0090594,inflammatory response to wounding,2/41,17/18800,0.0006181332439466,0.0075196759768185,0.0042860421936617,GRN/SIGLEC10,2
GO:0002833,GO:0002833,positive regulation of response to biotic stimulus,4/41,180/18800,0.0006241472030537,0.007523810829539,0.0042883989645225,CRTAM/GRN/HLA-E/LAG3,4
GO:0001906,GO:0001906,cell killing,4/41,185/18800,0.0006916283752234,0.0080774337336991,0.0046039512747447,CRTAM/HLA-E/ICAM1/LAG3,4
GO:0002819,GO:0002819,regulation of adaptive immune response,4/41,188/18800,0.0007345149819994,0.0084692770967933,0.0048272929709436,CD48/HLA-E/IL4R/TNFRSF1B,4
GO:0070371,GO:0070371,ERK1 and ERK2 cascade,5/41,335/18800,0.0007718089616021,0.0087840998001868,0.0050067346642328,CD74/EPHA2/ICAM1/MARCO/SEMA7A,5
GO:0042742,GO:0042742,defense response to bacterium,5/41,364/18800,0.001118775716998,0.011867972805915,0.0067644712825648,EPHA2/GRN/HLA-E/SLAMF8/SPON2,5
GO:0060444,GO:0060444,branching involved in mammary gland duct morphogenesis,2/41,23/18800,0.0011404219635257,0.0120015835209138,0.0068406263142146,CSF1/EPHA2,2
GO:0051251,GO:0051251,positive regulation of lymphocyte activation,5/41,371/18800,0.001217541273691,0.0125588450827458,0.0071582525755429,CD74/HLA-E/IL4R/TNFRSF4/VCAM1,5
GO:0002532,GO:0002532,production of molecular mediator involved in inflammatory response,3/41,97/18800,0.0012312593218378,0.0125588450827458,0.0071582525755429,GRN/IL4R/SLAMF8,3
GO:0032602,GO:0032602,chemokine production,3/41,98/18800,0.0012682264739854,0.0127838493268771,0.0072864998147953,CD74/EPHA2/IL4R,3
GO:0002685,GO:0002685,regulation of leukocyte migration,4/41,218/18800,0.0012726003854809,0.0127838493268771,0.0072864998147953,CD74/CSF1/ICAM1/SLAMF8,4
GO:0008630,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,3/41,101/18800,0.0013833084521496,0.0135882141500366,0.0077449692464287,CD74/EPHA2/TNFRSF1B,3
GO:0050870,GO:0050870,positive regulation of T cell activation,4/41,223/18800,0.0013834154677639,0.0135882141500366,0.0077449692464287,CD74/HLA-E/IL4R/VCAM1,4
GO:0050920,GO:0050920,regulation of chemotaxis,4/41,225/18800,0.0014295746463254,0.0139383528016729,0.0079445402171955,CD74/CSF1/SEMA7A/SLAMF8,4
GO:0019883,GO:0019883,antigen processing and presentation of endogenous antigen,2/41,26/18800,0.0014589165004158,0.0141206078799373,0.0080484214160474,CD74/HLA-E,2
GO:0071356,GO:0071356,cellular response to tumor necrosis factor,4/41,229/18800,0.0015251079492202,0.0145488715155827,0.0082925218291564,IL18BP/TNFRSF1B/TNFRSF4/VCAM1,4
GO:0040013,GO:0040013,negative regulation of locomotion,5/41,396/18800,0.0016237521752104,0.0149309500933498,0.0085102978225173,ADGRG1/BST2/CD74/SEMA7A/SLAMF8,5
GO:0007411,GO:0007411,axon guidance,4/41,234/18800,0.0016506881081806,0.0149918659688183,0.0085450184691685,EFNA4/EPHA2/NOTCH3/SEMA7A,4
GO:0002456,GO:0002456,T cell mediated immunity,3/41,112/18800,0.0018607724216011,0.0165596257116989,0.0094386054306579,HLA-E/ICAM1/TNFRSF1B,3
GO:0002526,GO:0002526,acute inflammatory response,3/41,113/18800,0.0019086419511155,0.0167606571336373,0.0095531887131472,CD163/HLA-E/VCAM1,3
GO:0034612,GO:0034612,response to tumor necrosis factor,4/41,249/18800,0.0020704815434043,0.0170106382978725,0.0096956722218563,IL18BP/TNFRSF1B/TNFRSF4/VCAM1,4
GO:0002507,GO:0002507,tolerance induction,2/41,31/18800,0.0020730273215041,0.0170106382978725,0.0096956722218563,HLA-E/PDCD1,2
GO:0001815,GO:0001815,positive regulation of antibody-dependent cellular cytotoxicity,1/41,1/18800,0.0021808510638298,0.0170106382978725,0.0096956722218563,HLA-E,1
GO:0060034,GO:0060034,notochord cell differentiation,1/41,1/18800,0.0021808510638298,0.0170106382978725,0.0096956722218563,EPHA2,1
GO:0060035,GO:0060035,notochord cell development,1/41,1/18800,0.0021808510638298,0.0170106382978725,0.0096956722218563,EPHA2,1
GO:0060611,GO:0060611,mammary gland fat development,1/41,1/18800,0.0021808510638298,0.0170106382978725,0.0096956722218563,CSF1,1
GO:0060945,GO:0060945,cardiac neuron differentiation,1/41,1/18800,0.0021808510638298,0.0170106382978725,0.0096956722218563,VCAM1,1
GO:1902228,GO:1902228,positive regulation of macrophage colony-stimulating factor signaling pathway,1/41,1/18800,0.0021808510638298,0.0170106382978725,0.0096956722218563,CSF1,1
GO:2000509,GO:2000509,negative regulation of dendritic cell chemotaxis,1/41,1/18800,0.0021808510638298,0.0170106382978725,0.0096956722218563,SLAMF8,1
GO:0043304,GO:0043304,regulation of mast cell degranulation,2/41,32/18800,0.0022081826502136,0.0170235476406003,0.0097030302500206,ADGRE2/IL4R,2
GO:0033006,GO:0033006,regulation of mast cell activation involved in immune response,2/41,34/18800,0.002490685601603,0.0188722806155751,0.0107567654854195,ADGRE2/IL4R,2
GO:0042092,GO:0042092,type 2 immune response,2/41,37/18800,0.0029446588566904,0.0216923202442866,0.0123641231526536,CD74/IL4R,2
GO:0045730,GO:0045730,respiratory burst,2/41,37/18800,0.0029446588566904,0.0216923202442866,0.0123641231526536,GRN/SLAMF8,2
GO:0031349,GO:0031349,positive regulation of defense response,4/41,289/18800,0.0035410821851471,0.0253809458243516,0.0144665548161344,CRTAM/GRN/HLA-E/LAG3,4
GO:0042063,GO:0042063,gliogenesis,4/41,291/18800,0.0036292796081261,0.0254429230956589,0.0145018804339788,ADGRG1/CSF1/GRN/TNFRSF1B,4
GO:0061564,GO:0061564,axon development,5/41,479/18800,0.0036998085750488,0.0256855820445797,0.014640190448526,EFNA4/EPHA2/GRN/NOTCH3/SEMA7A,5
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,5/41,486/18800,0.0039352394203811,0.0268719251624094,0.0153163787144637,CD74/CSF1/IL4R/TNFRSF1B/TNFRSF4,5
GO:0051452,GO:0051452,intracellular pH reduction,2/41,44/18800,0.0041425308310278,0.0268719251624094,0.0153163787144637,GRN/SLAMF8,2
GO:0060443,GO:0060443,mammary gland morphogenesis,2/41,44/18800,0.0041425308310278,0.0268719251624094,0.0153163787144637,CSF1/EPHA2,2
GO:1904646,GO:1904646,cellular response to amyloid-beta,2/41,45/18800,0.0043292445068887,0.0268719251624094,0.0153163787144637,ICAM1/VCAM1,2
GO:0019518,GO:0019518,L-threonine catabolic process to glycine,1/41,2/18800,0.0043570617721855,0.0268719251624094,0.0153163787144637,RIDA,1
GO:0032639,GO:0032639,TRAIL production,1/41,2/18800,0.0043570617721855,0.0268719251624094,0.0153163787144637,HLA-E,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/41,2/18800,0.0043570617721855,0.0268719251624094,0.0153163787144637,CSF1,1
GO:0140039,GO:0140039,cell-cell adhesion in response to extracellular stimulus,1/41,2/18800,0.0043570617721855,0.0268719251624094,0.0153163787144637,VCAM1,1
GO:1901253,GO:1901253,negative regulation of intracellular transport of viral material,1/41,2/18800,0.0043570617721855,0.0268719251624094,0.0153163787144637,BST2,1
GO:1903334,GO:1903334,positive regulation of protein folding,1/41,2/18800,0.0043570617721855,0.0268719251624094,0.0153163787144637,GRN,1
GO:0043300,GO:0043300,regulation of leukocyte degranulation,2/41,49/18800,0.0051143952886595,0.0308258552398297,0.0175700278337681,ADGRE2/IL4R,2
GO:0043303,GO:0043303,mast cell degranulation,2/41,50/18800,0.005320173264142,0.0319210395848521,0.0181942576978041,ADGRE2/IL4R,2
GO:0048013,GO:0048013,ephrin receptor signaling pathway,2/41,52/18800,0.0057430010396792,0.0336956609673215,0.0192057510316241,EFNA4/EPHA2,2
GO:0032496,GO:0032496,response to lipopolysaccharide,4/41,333/18800,0.0058432209906634,0.0341326477251973,0.0194548234235863,IL18BP/SPON2/TNFRSF1B/VCAM1,4
GO:1902743,GO:1902743,regulation of lamellipodium organization,2/41,53/18800,0.0059600177565777,0.0346622085316759,0.0197566608920722,ENPP2/EPHA2,2
GO:0031346,GO:0031346,positive regulation of cell projection organization,4/41,341/18800,0.0063482140180158,0.0347669837896827,0.0198163803770677,ENPP2/GRN/SCARB2/SEMA7A,4
GO:1904645,GO:1904645,response to amyloid-beta,2/41,55/18800,0.006405174524641,0.0347669837896827,0.0198163803770677,ICAM1/VCAM1,2
GO:0002355,GO:0002355,detection of tumor cell,1/41,3/18800,0.0065286417523612,0.0347669837896827,0.0198163803770677,CRTAM,1
GO:0014028,GO:0014028,notochord formation,1/41,3/18800,0.0065286417523612,0.0347669837896827,0.0198163803770677,EPHA2,1
GO:0045626,GO:0045626,negative regulation of T-helper 1 cell differentiation,1/41,3/18800,0.0065286417523612,0.0347669837896827,0.0198163803770677,IL4R,1
GO:0046103,GO:0046103,inosine biosynthetic process,1/41,3/18800,0.0065286417523612,0.0347669837896827,0.0198163803770677,ADA2,1
GO:0048320,GO:0048320,axial mesoderm formation,1/41,3/18800,0.0065286417523612,0.0347669837896827,0.0198163803770677,EPHA2,1
GO:1901491,GO:1901491,negative regulation of lymphangiogenesis,1/41,3/18800,0.0065286417523612,0.0347669837896827,0.0198163803770677,EPHA2,1
GO:0030336,GO:0030336,negative regulation of cell migration,4/41,346/18800,0.0066781934187156,0.0354211378928676,0.0201892331563697,ADGRG1/BST2/CD74/SLAMF8,4
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,2/41,57/18800,0.0068650532343719,0.0361232563046714,0.0205894244873812,CD74/PDCD1,2
GO:0046579,GO:0046579,positive regulation of Ras protein signal transduction,2/41,62/18800,0.008078305431447,0.0418430976644482,0.0238496023839595,ADGRG1/CSF1,2
GO:0060760,GO:0060760,positive regulation of response to cytokine stimulus,2/41,64/18800,0.0085886901566656,0.0420816292400025,0.0239855598907056,CD74/CSF1,2
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,4/41,373/18800,0.0086584327333597,0.0420816292400025,0.0239855598907056,CD74/EFEMP1/ENPP2/EPHA2,4
GO:0002265,GO:0002265,astrocyte activation involved in immune response,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,GRN,1
GO:0002901,GO:0002901,mature B cell apoptotic process,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,CD74,1
GO:0002905,GO:0002905,regulation of mature B cell apoptotic process,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,CD74,1
GO:0002906,GO:0002906,negative regulation of mature B cell apoptotic process,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,CD74,1
GO:0003332,GO:0003332,negative regulation of extracellular matrix constituent secretion,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,TNFRSF1B,1
GO:0006154,GO:0006154,adenosine catabolic process,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,ADA2,1
GO:0048319,GO:0048319,axial mesoderm morphogenesis,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,EPHA2,1
GO:0150098,GO:0150098,glial cell-neuron signaling,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,TNFRSF1B,1
GO:1904978,GO:1904978,regulation of endosome organization,1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,SCARB2,1
GO:2000566,GO:2000566,"positive regulation of CD8-positive, alpha-beta T cell proliferation",1/41,4/18800,0.0086956006121875,0.0420816292400025,0.0239855598907056,HLA-E,1
GO:0042093,GO:0042093,T-helper cell differentiation,2/41,65/18800,0.008849193686809,0.0425146044518435,0.0242323457937792,IL4R/LY9,2
GO:0061180,GO:0061180,mammary gland epithelium development,2/41,68/18800,0.0096517587588078,0.0452234350324351,0.0257763168637679,CSF1/EPHA2,2
GO:1901215,GO:1901215,negative regulation of neuron death,3/41,209/18800,0.0105840273759643,0.0481526386907497,0.027445895514772,CSF1/GRN/TNFRSF1B,3
GO:0001788,GO:0001788,antibody-dependent cellular cytotoxicity,1/41,5/18800,0.010857947940071,0.0481526386907497,0.027445895514772,HLA-E,1
GO:0002885,GO:0002885,positive regulation of hypersensitivity,1/41,5/18800,0.010857947940071,0.0481526386907497,0.027445895514772,HLA-E,1
GO:0046102,GO:0046102,inosine metabolic process,1/41,5/18800,0.010857947940071,0.0481526386907497,0.027445895514772,ADA2,1
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,1/41,5/18800,0.010857947940071,0.0481526386907497,0.027445895514772,TNFRSF1B,1
GO:1905123,GO:1905123,regulation of glucosylceramidase activity,1/41,5/18800,0.010857947940071,0.0481526386907497,0.027445895514772,SCARB2,1
GO:1990834,GO:1990834,response to odorant,1/41,5/18800,0.010857947940071,0.0481526386907497,0.027445895514772,IL4R,1
GO:0150076,GO:0150076,neuroinflammatory response,2/41,73/18800,0.0110586059981482,0.04871664967955,0.0277673687940914,GRN/TNFRSF1B,2
GO:0007040,GO:0007040,lysosome organization,2/41,74/18800,0.0113502209417285,0.0496712639232077,0.0283114769364636,GRN/SCARB2,2
GO:0080171,GO:0080171,lytic vacuole organization,2/41,74/18800,0.0113502209417285,0.0496712639232077,0.0283114769364636,GRN/SCARB2,2
